News & Updates

CDK4/6 inhibitor-induced liver injury common in breast cancer

Liver injury occurs in around one in 20 patients treated with cyclin-dependent kinase 4/6 inhibitors for metastatic breast cancer, according to a multicentre retrospective study in Spain.

CDK4/6 inhibitor-induced liver injury common in breast cancer

2 hours ago

ALT helps spot liver fibrosis in overweight children

10 hours ago

Alanine aminotransferase (ALT) appears to be a useful primary screening measure to identify early signs of fibrosis, such as increased liver stiffness, in children with overweight or obesity and additional risk factors, according to a study.

ALT helps spot liver fibrosis in overweight children

10 hours ago

FMT prevents hepatic encephalopathy recurrence in cirrhosis

30 Jun 2025 by

A phase II study has demonstrated the safety of faecal microbiota transplantation (FMT) in patients with cirrhosis treated with lactulose and rifaximin, with no related adverse events (AEs) seen. FMT also results in lower rates of hepatic encephalopathy (HE) recurrence.

FMT prevents hepatic encephalopathy recurrence in cirrhosis

30 Jun 2025

Diabetes in CHD patients ups risk of hepatocellular carcinoma

26 Jun 2025 by

The presence of diabetes mellitus predisposes patients with chronic hepatitis B (CHB) to a higher risk of developing hepatocellular carcinoma (HCC), reveals a study presented at EASL 2025.

Diabetes in CHD patients ups risk of hepatocellular carcinoma

26 Jun 2025

Injectable extended-release naltrexone poses no hepatotoxicity signal in advanced ALD

24 Jun 2025

The use of the injectable extended-release naltrexone for alcohol use disorder in patients with advanced alcohol-associated liver disease (ALD) does not appear to carry a substantial hepatotoxicity or liver decompensation risk, according to a study.

Injectable extended-release naltrexone poses no hepatotoxicity signal in advanced ALD

24 Jun 2025

Carvedilol trumps propranolol in preventing decompensation in cirrhosis

23 Jun 2025

A recent study has provided data bolstering the current recommendation of using carvedilol to prevent a first decompensation of cirrhosis in patients with compensated cirrhosis.

Carvedilol trumps propranolol in preventing decompensation in cirrhosis

23 Jun 2025

Metabolic burden ups risk of death in CHB patients with SLD

23 Jun 2025

Metabolic burden in patients with chronic hepatitis B (CHB) and concurrent steatotic liver disease (SLD) may exacerbate the risks of all-cause, liver-related, and cardiovascular mortality, suggests a study.

Metabolic burden ups risk of death in CHB patients with SLD

23 Jun 2025

Long-term odevixibat shows sustained benefits in ALGS

20 Jun 2025 by

Long-term treatment with odevixibat led to sustained improvements in pruritus scores and reductions in serum bile acid (sBA) levels among patients with Alagille syndrome (ALGS), based on a pooled analysis of the phase III ASSERT and ASSERT-EXT studies presented at ESPGHAN 2025.

Long-term odevixibat shows sustained benefits in ALGS

20 Jun 2025

Study ties energy drink intake to unhealthy lifestyle in young individuals

19 Jun 2025 by

A study presented at ESPGHAN 2025 reports that schoolchildren who consume energy drinks have unhealthier lifestyles and a different cardiovascular risk profile than their counterparts who do not or rarely consume energy drinks.

Study ties energy drink intake to unhealthy lifestyle in young individuals

19 Jun 2025

Coil plus glue therapy beneficial for gastric varices

18 Jun 2025 by

Cyanoacrylate (CYA) injection delivers better results when augmented with endoscopic ultrasonography (EUS)-guided coil embolization for gastric variceal obliteration in a single-centre study.

Coil plus glue therapy beneficial for gastric varices

18 Jun 2025

News & Updates

Filter by Specialty:

Specialty:

CDK4/6 inhibitor-induced liver injury common in breast cancer

CDK4/6 inhibitor-induced liver injury common in breast cancer

ALT helps spot liver fibrosis in overweight children

ALT helps spot liver fibrosis in overweight children

FMT prevents hepatic encephalopathy recurrence in cirrhosis

FMT prevents hepatic encephalopathy recurrence in cirrhosis

Diabetes in CHD patients ups risk of hepatocellular carcinoma

Diabetes in CHD patients ups risk of hepatocellular carcinoma

Injectable extended-release naltrexone poses no hepatotoxicity signal in advanced ALD

Injectable extended-release naltrexone poses no hepatotoxicity signal in advanced ALD

Carvedilol trumps propranolol in preventing decompensation in cirrhosis

Carvedilol trumps propranolol in preventing decompensation in cirrhosis

Metabolic burden ups risk of death in CHB patients with SLD

Metabolic burden ups risk of death in CHB patients with SLD

Long-term odevixibat shows sustained benefits in ALGS

Long-term odevixibat shows sustained benefits in ALGS

Study ties energy drink intake to unhealthy lifestyle in young individuals

Study ties energy drink intake to unhealthy lifestyle in young individuals

Coil plus glue therapy beneficial for gastric varices

Coil plus glue therapy beneficial for gastric varices